CSIMarket Company Name, Ticker, Competitors, else..
 
Joint Corp  (JYNT)
Other Ticker:  
 
    Sector • Conglomerates    Industry • Conglomerates
   Industry • Conglomerates
   Sector • Conglomerates
 
Price: $11.6800 $-0.32 -2.667%
Day's High: $12.04 Week Perf: 1.92 %
Day's Low: $ 11.49 30 Day Perf: 0.43 %
Volume (M): 26 52 Wk High: $ 17.82
Volume (M$): $ 308 52 Wk Avg: $11.32
Open: $12.04 52 Wk Low: $7.31



 Market Capitalization (Millions $) 178
 Shares Outstanding (Millions) 15
 Employees -
 Revenues (TTM) (Millions $) 120
 Net Income (TTM) (Millions $) -14
 Cash Flow (TTM) (Millions $) 4
 Capital Exp. (TTM) (Millions $) 3

Joint Corp
The Joint Corp is a company that operates a chain of chiropractic clinics across the United States. They provide affordable, convenient, and accessible chiropractic care to individuals suffering from musculoskeletal disorders. The company's clinics are staffed with licensed chiropractors who specialize in spinal adjustments and offer personalized treatment plans for their patients. Joint Corp aims to make chiropractic care a mainstream option for healthcare and wellness by expanding their network of clinics and improving accessibility to their services.


   Company Address: 16767 N. Perimeter Drive Scottsdale 85260 AZ
   Company Phone Number: 245-5960   Stock Exchange / Ticker: NASDAQ JYNT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Joint Corp

The Joint Corp Reports Mixed Financial Results: Revenue Grows 3.25% Amidnet Loss Increase



In its most recent fiscal period, The Joint Corp (NASDAQ: JYNT) has faced mixed financial results. The nation's largest provider of chiropractic care, through The Joint Chiropractic network, reported a net loss per share of $-0.24, representing a significant increase from $-0.02 per share in the same period last year. However, the company managed to achieve a revenue growth of 3.253%, reaching $30.26 million from the previous year's financial reporting period.
Behind Industry Peers
While The Joint Corp experienced a positive revenue increase, it fell behind its conglomerate industry peers. Comparatively, the industry saw an average revenue advance of 6.47% relative to the Q2 of 2023, indicating a lag in the company's performance compared to its competitors.
Joint Corp

Joint Corp's Revenue Rises 5.022% in Q1 of 2024 Earnings Season

The Conglomerates company's mixed earnings in the first quarter of the 2024 earnings season have garnered attention in the stock market. The company's revenue showed a minimal increase of 5.022% to $29.72 million compared to the previous year. However, the income per share took a significant hit, diving by -62.5% to $0.06 per share from $0.16 in the prior year reporting period.
To fully understand the performance of the Conglomerates company in the first quarter of 2024, it is essential to compare it with its contemporaries in the industry. It becomes evident that Joint Corp, one of the Conglomerates industries, has underperformed as its competitors have reported a top-line elevation of 8.34% relative to the corresponding period a year ago. The revenue of Joint Corp decreased by -2.914% from $30.61 million in the prior period, while the income per share turned positive from $-0.73 per share.
Joint Corp

Joint Corp's Tax Charge Signals Financial Growth Despite Challenges

In the world of finance, numbers tell a story. The recent financial results of The Joint Corp. (JYNT) paint a picture of growth and success, with revenue increasing by over 12% in the most recent fiscal period. However, the company also reported a significant increase in shortfall per share, indicating some challenges that need to be addressed.
Looking back at the previous reporting season, we see a similar pattern of revenue growth but a much smaller shortfall per share. This suggests that there may be some underlying issues impacting the company's profitability that need to be explored further.
Management Announcement

The Joint Corp.: Charting a Successful Path in 2023 with Exceptional Sales Growth and Expanded Clinics

Published Thu, Jan 11 2024 12:05 PM UTC


The Joint Corp. Reports Strong Operating Metrics in 2023 - Impressive Sales Growth, Expanded Clinic Count
The Joint Corp., a leading provider of chiropractic services, has announced its impressive operating metrics for the year 2023. The company has reported a significant 12% growth in its system-wide sales, compared to the previous year. Additionally, The Joint Cor...
Joint Corp

Elevated Performance by Joint Corp in Q3 2023 Demonstrates Remarkable Financial Conduct 2.



The recently released financial results of Joint Corp for the period of July to September 30, 2023, showcase significant growth in revenue despite challenging market conditions in the conglomerates sector. This article examines the facts and interprets the financial results to provide a comprehensive understanding of Joint Corp's performance in the industry.
Revenue Growth and Profitability:
Joint Corp experienced a remarkable increase in revenue, recording a growth of 10.792% from the corresponding reporting period a year ago, reaching $29.47 million. This boost in revenue comes at a time when many competitors in the conglomerates industry are facing revenue contractions. Comparing the figures from the prior reporting period, revenue expanded by 0.569% from $29.31 million, demonstrating consistent growth.

However, it is important to note that despite the revenue surge, Joint Corp registered a deficit per stock at $-0.05 deficit per share, indicating a decrease in profitability. In the previous reporting period, the deficit per share stood at $-0.02, representing an increase in losses. While the company experienced growth in revenue, it will need to address profitability concerns to ensure long-term sustainability.






Joint's Segments
Revenue recognized at a point in time    92.95 % of total Revenue
Revenue recognized over time    7.05 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com